TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 93 filers reported holding TREACE MED CONCEPTS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,488,919 | -35.5% | 4,308,842 | +25.8% | 0.02% | -33.3% |
| Q2 2023 | $87,591,829 | +8.1% | 3,424,231 | +6.4% | 0.04% | +2.9% |
| Q1 2023 | $81,054,367 | +10.3% | 3,217,720 | +0.7% | 0.04% | +6.1% |
| Q4 2022 | $73,485,742 | +2.2% | 3,196,422 | -1.9% | 0.03% | -5.7% |
| Q3 2022 | $71,890,000 | +51.7% | 3,257,346 | -1.4% | 0.04% | +59.1% |
| Q2 2022 | $47,393,000 | -20.7% | 3,304,942 | +4.6% | 0.02% | -4.3% |
| Q1 2022 | $59,730,000 | +30.5% | 3,158,645 | +28.7% | 0.02% | +43.8% |
| Q4 2021 | $45,759,000 | -8.4% | 2,454,893 | +32.2% | 0.02% | -20.0% |
| Q3 2021 | $49,967,000 | -9.8% | 1,857,517 | +4.8% | 0.02% | -9.1% |
| Q2 2021 | $55,417,000 | – | 1,772,789 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,907,823 | $25,011,560 | 2.31% |
| FORMULA GROWTH LTD | 222,269 | $2,913,947 | 0.99% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,193,939 | $15,652,540 | 0.94% |
| EMERALD ADVISERS, LLC | 1,473,281 | $19,314,713 | 0.94% |
| Perceptive Advisors | 1,834,060 | $24,044,527 | 0.80% |
| NEXT CENTURY GROWTH INVESTORS LLC | 512,738 | $6,721,995 | 0.73% |
| OBERWEIS ASSET MANAGEMENT INC/ | 355,600 | $4,661,916 | 0.50% |
| Novo Holdings A/S | 360,000 | $4,719,600 | 0.35% |
| TimesSquare Capital Management, LLC | 1,433,429 | $18,792 | 0.29% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 677,733 | $8,885,080 | 0.18% |